GLP-1 analog liraglutide-induced cardiac dysfunction due to energetic starvation in heart failure with non-diabetic dilated cardiomyopathy

BACKGROUND: Glucagon-like peptide-1 (GLP-1) reduces cardiovascular events in diabetic patients; however, its counter-protective effects have also been suggested in patients with heart failure and the clear explanation for its mechanisms have not yet been offered. METHODS: The effects of GLP-1 analog...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiraki, Aya, Oyama, Jun-ichi, Nishikido, Toshiyuki, Node, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881987/
https://www.ncbi.nlm.nih.gov/pubmed/31779634
http://dx.doi.org/10.1186/s12933-019-0966-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881987/
https://www.ncbi.nlm.nih.gov/pubmed/31779634
http://dx.doi.org/10.1186/s12933-019-0966-2

Ejemplares similares